Kinetics, diagnostic and prognostic value of procalcitonin after cardiac surgery;Cinétique et intérêt diagnostique et pronostique de la procalcitonine aprés chirurgie cardiaque

Annales de Biologie Clinique

Volumn 70, Issue 5, 2012, Pages 567-580

  Kallel, Samy ^a   Abid, Mohamed ^a   Jarraya, Anouar ^a   Abdenadher, Mohamed ^a   Mnif, Emna ^a   Frikha, Imed ^a   Ayadi, Fatma ^a   Karoui, Abdelhamid ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

C reactive protein; Cardiac surgery; Cardiopulmonary bypass; Procalcitonin; Severe systemic inflammatory response

Indexed keywords

BIOLOGICAL MARKER; CALCITONIN; PROCALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; BLOOD; EARLY DIAGNOSIS; EVALUATION; FEMALE; HEART SURGERY; HUMAN; KINETICS; MALE; METABOLISM; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PROGNOSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; BIOLOGICAL MARKERS; CALCITONIN; CARDIAC SURGICAL PROCEDURES; EARLY DIAGNOSIS; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN PRECURSORS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84867507917     PISSN: 00033898     EISSN: 19506112     Source Type: Journal    
DOI: 10.1684/abc.2012.0745     Document Type: Article

References (39)

1. Delannoy B, Guye M, Slaiman D, Lehot JJ, Cannesson M. Effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and C-reactive protein concentrations. Crit Care 2009;13:R180.
2. Aouifi A, Piriou V, Blanc P, Bouvier H, Bastien O, Chiari P, et al. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anaesth 1999;83:602-7.
3. Aouifi A, Piriou V, Bastien O, Blanc P, Bouvier H, Evans R, et al. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 2000;28:3171-6.
4. Corral L, Carriá M, Josep L, Torrado H, Javierre C, Rodriguez-Castro D, et al. Is C-reactive protein a biomarker for immediate clinical outcome after cardiac surgery ? J Cardiothorac Vasc Anesth 2009;23:166-9.
5. Chourrout P. La procalcitonine de la découverte è l'utilisation clinique. Med Nuc 2008;32:132-7.
6. Heinz R, Güther S, Eva T, Marcel A, Claude B. Procalcitonin release patterns in a baboon model trauma and sepsis: relationship to cytokines and noepterin. Crit Care Med 2000;28:A11.
7. Nijsten MW, Olinga P, The TH, De Vries EG, Koops HS, Groothuis GM, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000;28:458-61.
8. Sponholz C, Sakr Y, Reinhart K, Brunkhorst F. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care 2006;10:R145.
9. Aouni Z, Jebali A, Mazigh C, Nsiri B, Ferjani M, Machghoul S. Place de la procalcitonine dans le diagnostic des complications post-opératoires en chirurgie cardiaque. Feuill Biol 2006;48:25-8.
10. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79:1605-8.
11. Meisner M, Reinhart K. Is procalcitonin really a marker of sepsis ? Int J Intensive Care 2001;8:15-25.
12. Kilger E, Pichler B, Goetz AE, Rank N, Welte M, Mörstedt K, et al. Procalcitonin as a marker of systemic inflammation after conventional or minimally invasive coronary artery bypass grafting. Thorac Cardiovasc Surg 1998;46:130-3.
13. Franke A, Lante W, Fackeldey V, Becker HP, Kurig E, Zöller LG. Proinflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know ? Eur J Cardiothorac Surg 2005;28:569-75.
14. Celebi S, Koner O, Menda F, Balci H, Hatemi A, Korkut K, et al. Procalcitonin kinetics in pediatric patients with systemic inflammatory response after open heart surgery. Intensive Care Med 2006;32:881-7.
15. Beghetti M, Rimensberger PC, Kalangos A, Habre W, Gervaix A. Kinetics of procalcitonin, interleukin 6 and C-reactive protein after cardiopulmonary-bypass in children. Cardiol Young 2003;13:161-7.
16. Meisner M, Rauschmayer C, Schmidt J, Feyrer R, Cesnjevar R. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med 2002;28:1094-102.
17. Hensel M, Volk T, Döcke WD, Kern F, Tschirna D, Egerer K, et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulomonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 1988;89:93-104.
18. Kerbaul F, Guidon C, Lejeune PJ, Mollo M, Mesana T, Gouin F. Hyperprocalcitonemia is related to non infectious postoperative severe SIRS associated with cardiovascular dysfunction after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2002;16:47-43.
19. Hensel M, Volk T, Döcke WD, Kern F, Tschirna D, Egerer K, et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulomonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 1988;89:93-104.
20. Hausfater P. Le dosage de la procalcitonine en pratique clinique chez l'adulte. Rev Med Interne 2007;28:296-305.
21. Adamik B, Kubler-Kielb J, Golebiowska B, Gamian A, Kubler A. Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications. Intensive Care Med 2000;26:1259-67.
22. Taylor KM. SIRS-the systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996;61:1607-8.
23. Boeken U, Feindt P, Micek M, Petzold T, Schulte HD, Gams E. Procalcitonin (PCT) in cardiac surgery: diagnostic value in systemic inflammatory response syndrome (SIRS), sepsis and after heart transplantation (HTX). Cardiovasc Surg 2000;8:550-4.
24. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee American College of Chest Physicians/Society of Critical Care Medecine. Chest 1992;101:1644-55.
25. Loop FD, Lytle BW, Cosgrove DM, Mahfood S, McHenry MC, Goormastic M, et al. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity and cost of care. Ann Thorac Surg 1990;49:179-87.
26. Nelson RM, Dries DJ. The economic implications of infection in cardiac surgery. Ann Thorac Surg 1986;42:240-2.
27. Assicot M, Bohuon C, Gendrel D, Raymond J, Carsin H, Guilbaud J. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8.
28. Sinha M, Desai S, Mantri S, Kulkarni A. Procalcitonin as an adjunctive biomarker in sepsis. Indian J Anaesth 2011;55:266-70.
29. Mimoz O, Benoist JF, Edouard AR, Assicot M, Bohuon C, Samii K. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998;24:185-8.
30. Carsin H, Assicot M, Feger F, Roy O, Pennacino I, Le Bever H, et al. Evolution and significance of circulating procalcitonin levels compared with IL-6, TNFa and endotoxin levels early after thermal injury. Burns 1997;23:218-24.
31. Nylén ES, Al Arifi A, Becker KL, Snider Jr. RH, Alzeer A. Effect of classic heatstroke on serum procalcitonin. Crit Care Med 1997;25:1362-5.
32. Jebali A, Hausfater P, Abbes Z, Aouni Z, Riou B, Ferjani M. Assessment of the accuracy of procalcitonin to diagnose postoperative infection after cardiac surgery. Anesthesiology 2007;107:232-8.
33. Macrina F, Tritapepe L, Pompei F, Sciangula A, Evangelista E, Toscano F, et al. Procalcitonin is useful whereas C-reactive protein is not, to predict complications following coronary artery bypass surgery. Perfusion 2005;20:169-75.
34. Dörge H, Schondube FA, Dorge P, Seipelt R, Voss M, Messmer BJ. Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection. Thorac Cardiovasc Surg 2003;51:322-6.
35. Giamarellos-Bourboulis EJ, Mega A, Grecka P, Scarpa N, Koratzanis G, Thomopoulos G, et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient ? Intensive Care Med 2002;28:1351-6.
36. Giamarellos-Bourboulis EJ, Giannopoulou P, Grecka P, Voros D, Mandragos K, Giamarellou H. Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis ? J Crit Care 2004;19:152-7.
37. Meisner M, Lohs T, Huettemann E, Schmit J, Hueller M, Reinhart K. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 2001;18:79-87.
38. Loebe M, Locziewski S, Brunkhorst FM, Harke C, Hetzer R. Procalcitonin in patients undergoing cardiopulmonary bypass in open heart surgery: first results of the Procalcitonin in Heart Surgery study (Pro-Hearts). Intensive Care Med 2000;26:S193-8.
39. Fritz HG, Brandes H, Bredle DL, Bitterlich A, Vollandt R, Specht M, et al. Post-operative hypoalbuminaemia and procalcitonin elevation for prediction of outcome in cardiopulmonary bypass surgery. Acta Anaesthesiol Scand 2003;47:1276